Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Aspen Aerogels (ASPN) Equity Average (2016 - 2025)

Historic Equity Average for Aspen Aerogels (ASPN) over the last 12 years, with Q3 2025 value amounting to $307.3 million.

  • Aspen Aerogels' Equity Average fell 4007.66% to $307.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $307.3 million, marking a year-over-year decrease of 4007.66%. This contributed to the annual value of $551.4 million for FY2024, which is 1788.05% up from last year.
  • According to the latest figures from Q3 2025, Aspen Aerogels' Equity Average is $307.3 million, which was down 4007.66% from $311.8 million recorded in Q2 2025.
  • Aspen Aerogels' Equity Average's 5-year high stood at $561.2 million during Q4 2024, with a 5-year trough of $67.2 million in Q1 2021.
  • Its 5-year average for Equity Average is $323.8 million, with a median of $314.9 million in 2022.
  • In the last 5 years, Aspen Aerogels' Equity Average surged by 18384.62% in 2023 and then crashed by 4007.66% in 2025.
  • Aspen Aerogels' Equity Average (Quarter) stood at $135.4 million in 2021, then skyrocketed by 132.53% to $314.9 million in 2022, then soared by 42.55% to $448.9 million in 2023, then rose by 25.0% to $561.2 million in 2024, then tumbled by 45.25% to $307.3 million in 2025.
  • Its Equity Average stands at $307.3 million for Q3 2025, versus $311.8 million for Q2 2025 and $464.8 million for Q1 2025.